{"id":"W2318605753","doi":"10.1056/nejm200103153441101","title":"Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2","year":2001,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11512,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Trastuzumab; Epirubicin; Anthracycline; Internal medicine; Breast cancer; Oncology; Cyclophosphamide; Chemotherapy; Doxorubicin; Metastatic breast cancer; Paclitaxel; Cancer; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369638,0.0003356146,0.0008390681,0.0003533569,0.0002226064,0.0001821425,0.0002903158,0.0003491369,0.001416809],"category_scores_gemma":[0.001643994,0.0001412686,0.0004193588,0.0002955903,0.0003335623,0.0001703751,0.0002415541,0.0005503112,0.0002051872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000498793,"about_ca_system_score_gemma":0.0004934613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00040331,"about_ca_topic_score_gemma":0.001168412,"domain_scores_codex":[0.9996462,0.0001197381,0.0000472175,0.00007252943,0.00006628254,0.00004814286],"domain_scores_gemma":[0.9989654,0.0004144843,0.0002387291,0.00008413076,0.00003834279,0.0002588757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1876869,0.01825456,0.1336202,0.00133779,0.00232194,0.0012692,0.0002920346,0.007941682,0.09358046,0.0006239227,0.0023629,0.5507085],"study_design_scores_gemma":[0.07531156,0.5644845,0.2811874,0.0004101758,0.00227368,0.006621256,0.0001188972,0.005788987,0.03450253,0.0005701912,0.02864737,0.00008345491],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948978,0.002763743,0.0005166555,0.0002225841,0.0001017672,0.0002740576,0.00007373931,0.00002431936,0.001125354],"genre_scores_gemma":[0.996989,0.001079167,0.0009193358,0.0001575154,0.00011535,0.0002120121,0.0001737044,0.000003912216,0.0003500027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001416809,"threshold_uncertainty_score":0.004739702,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1035786067360863,"score_gpt":0.4099576805019227,"score_spread":0.3063790737658363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}